Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein
- PMID: 1704033
Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein
Abstract
Previous studies have indicated that in transgenic mice expressing human class I MHC molecules, it is difficult to demonstrate a significant CTL response to a viral Ag in the context of the transgenic molecule. In this paper, a procedure is reported for the isolation of influenza-specific murine CTL restricted by the human class I molecule HLA-A2.1. The principal specificity of such CTL is for a fragment of the influenza M1 protein that has been previously shown to be immunodominant for human HLA-A2.1-restricted CTL. CTL of this specificity were also established through the use of peptide-pulsed rather than virus-infected stimulators. The dependence of murine CTL recognition upon peptide length and HLA-A2 structure was established to be similar to that previously reported for human CTL. However, the fine specificity of CTL maintained on virus-infected stimulators was somewhat different from that of CTL maintained with M1 peptide. This suggests that differences in surface density or peptide structure between peptide-pulsed and virus-infected stimulators may result in the outgrowth of T cells with different receptor structures. The immunodominance of the M1 peptide determinant in both mice and humans suggests that species-specific differences in TCR structure, Ag-processing systems, and self-tolerance are of less importance than limitations on the ability of antigenic peptides to bind to appropriate class I molecules. These results thus establish the utility of the transgenic system for the identification of human class I MHC-restricted T cell epitopes.
Similar articles
-
Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice.J Immunol. 1994 Nov 15;153(10):4458-67. J Immunol. 1994. PMID: 7963521
-
Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I molecules.J Immunol. 1992 Jul 1;149(1):136-42. J Immunol. 1992. PMID: 1607650
-
Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice.Vaccine. 2005 Nov 1;23(45):5231-44. doi: 10.1016/j.vaccine.2005.07.032. Epub 2005 Jul 25. Vaccine. 2005. PMID: 16099553
-
[Antigenic epitopes of influenza virus specific CTL].Nihon Rinsho. 1997 Oct;55(10):2670-5. Nihon Rinsho. 1997. PMID: 9360389 Review. Japanese.
-
The use of chimeric A2K(b) tetramers to monitor HLA A2 immune responses in HLA A2 transgenic mice.J Immunol Methods. 2002 Oct 1;268(1):35-41. doi: 10.1016/s0022-1759(02)00198-9. J Immunol Methods. 2002. PMID: 12213341 Review.
Cited by
-
Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax encapsulated CTL/T helper peptides.J Transl Med. 2007 Jun 7;5:26. doi: 10.1186/1479-5876-5-26. J Transl Med. 2007. PMID: 17555571 Free PMC article.
-
TCR Transgenic Mice: A Valuable Tool for Studying Viral Immunopathogenesis Mechanisms.Int J Mol Sci. 2020 Dec 18;21(24):9690. doi: 10.3390/ijms21249690. Int J Mol Sci. 2020. PMID: 33353154 Free PMC article. Review.
-
Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):297-302. doi: 10.1073/pnas.97.1.297. Proc Natl Acad Sci U S A. 2000. Retraction in: Proc Natl Acad Sci U S A. 2001 May 8;98(10):5943. doi: 10.1073/pnas.101132998. PMID: 10618412 Free PMC article. Retracted.
-
Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.J Exp Med. 1997 Mar 3;185(5):833-41. doi: 10.1084/jem.185.5.833. J Exp Med. 1997. PMID: 9120389 Free PMC article.
-
Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.J Clin Invest. 1998 Sep 15;102(6):1239-48. doi: 10.1172/JCI3714. J Clin Invest. 1998. PMID: 9739058 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials